NIROPHARM collaborated with NAFDAC on a capacity-building workshop for its Regulatory Affairs Committee, reinforcing regulatory compliance and pharmaceutical industry standards in Nigeria.
Continue reading “Partnership with NAFDAC for Capacity-Building Workshop”Category: News
NIROPHARM Strengthens Industry Collaboration.
NIROPHARM’s Regulatory Affairs Committee met at Codix Pharmaceuticals Limited to align on pharmaceutical regulatory affairs, share industry insights, and address shared regulatory challenges in Nigeria.
Continue reading “NIROPHARM Strengthens Industry Collaboration.”NIROPHARM Elects New Executives December 2024
NIROPHARM is pleased to present to you the new Executive Committee Members of NIROPHARM duly elected in accordance with our constitution as an association at the Annual General Meeting held on 18th December 2024.
Continue reading “NIROPHARM Elects New Executives December 2024”NIROPHARM, PSN Fault nationwide ban of Codeine, shutdown of EMZOR others.
The Pharmaceutical Society of Nigeria (PSN) and the Nigeria Representative of Overseas Pharmaceutical Manufacturers (NIROPHARM) have blamed weak regulatory control and extremely poor funding of regulatory agencies for the ongoing drug abuse crisis in the country.
Continue reading “NIROPHARM, PSN Fault nationwide ban of Codeine, shutdown of EMZOR others.”NIROPHARM seeks common tariff for growth of locally made goods
The Nigerian Representatives of Overseas Pharmaceutical Manufacturers, NIROPHARM, last week in Lagos urged the Federal Government to urgently implement the Economic Committee of West African States’ (ECOWAS) Common External Tariff (CET) with a view to increasing patronage for locally manufactured goods.
Continue reading “NIROPHARM seeks common tariff for growth of locally made goods”NIROPHARM has no rift with PMG-MAN, WAPMA – Asuni
In Nigerian pharmacy circle, Pharm. Lekan Asuni needs no introduction. A colossus of sort, the pharmacist is the current president, Representatives of Overseas Pharmaceutical Manufacturers (NIROPHARM). In this interview with Adebayo Folorunsho-Francis, Asuni, who was appointed managing director of GlaxoSmithKline Pharmaceuticals (Anglophone West Africa) at a relatively young age of 40, bares his mind on how NIROPHARM’s cordial relationship with all regulatory agencies is aiding its progress; why people wrongly believe the body has a rift with PMG-MAN, as well as his choice of new PSN leadership. Excerpts:
Continue reading “NIROPHARM has no rift with PMG-MAN, WAPMA – Asuni”
